Tests | Normal range | 24-Jan | 25-Jan | 26-Jan | 27-Jan | 28-Jan | 29-Jan | 30-Jan | 31-Jan | 1-Feb | 2-Feb | 7-Feb | 12-Feb | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Routine Blood Tests | white blood cell count (109/L) | 3.5–9.5 | 5.61 | 4.59 | – | 9.89 | 9.48 | 7.41 | – | 7.02 | – | – | 5.12 | 3.63 |
Neutrophil ratio (%) | 40–75 | 80.4 | 73.1 | – | 87.4 | 88.3 | 80.1 | – | 78.2 | – | – | 75.7 | 54.2 | |
Lymphocyte ratio (%) | 20–50 | 14.8 | 18.7 | – | 7.9 | 7.1 | 11.3 | – | 13.4 | – | – | 13.5 | 32.8 | |
Eosinophil ratio (%) | 0.4–8 | 0.5 | 0.2 | – | 0 | 0 | 0 | – | 0.3 | – | – | 1 | 2.5 | |
T cell ratio (%) | 65–79 | – | – | – | – | 49.1 | – | – | – | – | – | 66 | ||
T cell absolute count (/μl) | – | – | – | – | 337 | – | – | – | – | – | 920 | |||
Th-cell absoluet count(/μl) | – | – | – | – | 223 | – | – | – | – | – | 534 | |||
Ts-cell absolute count(/μl) | – | – | – | – | 110 | – | – | – | – | – | 379 | |||
Th/Ts ratio | 0.9–3.6 | – | – | – | – | 2.03 | – | – | – | – | – | 1.41 | ||
Red blood cell (1012/L) | 4.3–5.8 | 5.05 | 4.94 | – | 4.8 | 4.53 | 4.86 | – | 4.86 | – | – | 4.53 | 4.14 | |
Hemoglobin (g/L) | 130–175 | 158 | 155 | – | 151 | 141 | 151 | – | 157 | – | – | 142 | 129 | |
Platelet (109/L) | 125–350 | 207 | 257 | – | 324 | 283 | 329 | – | 286 | – | – | 179 | 127 | |
Biochemical tests | Albumin (ALB) (g/L) | 35–50 | 39.7 | – | 39.5 | – | – | 40.3 | – | 38.9 | 37.9 | – | 41.7 | 40.7 |
Total Bilirubin (TB) (μmol/L) | 1.7–21 | 19 | – | 17.2 | – | – | 13.7 | – | 19.1 | 14.1 | – | 8.2 | 21.9 | |
Direct Bilirubin (DB) (μmol/L) | 0.3–6.8 | 0 | – | 7.8 | – | – | 6.2 | – | 6.9 | 5.3 | – | 3.2 | 10.6 | |
Alanine aminotransferase (ALT) (U/L) | 21–72 | 65.2 | – | 51 | – | – | 173 | – | 265 | 242 | – | 134 | 46 | |
Aspartate aminotransferase (AST) (U/L) | 17–59 | 59 | – | 30 | – | – | 62 | – | 64 | 53 | – | 31 | 27 | |
Alkaline phosphatase (ALP) (U/L) | 45–125 | 231 | – | 172 | – | – | 123 | – | 95 | 97 | – | 96 | 77 | |
γ-glutamyl transpeptadase (GGT) (U/L) | 0–49 | 508 | – | 473 | – | – | 371 | – | 277 | 230 | – | 135 | 104 | |
Lactate dehydrogenase (LDH) (U/L) | 313–618 | 770 | – | – | – | 257 | – | 206 | 201 | – | 195 | 151 | ||
Blood urea nitrogen (BUN) (mmol/L) | 3.2–7.1 | 4.34 | – | 5.38 | – | – | 5.17 | – | 4.29 | – | – | 1.2 | 1.66 | |
creatinine (Cr) (μmol/L) | 57–97 | 61.8 | – | 55 | – | – | 61 | – | 66 | – | – | 66 | 57 | |
cystatin c (Cys-C) (mg/L) | 0–1.21 | – | – | 0.7 | – | – | 1.17 | – | 0.91 | – | – | 0.65 | 0.5 | |
B2 microglobulin (Β2-M) (mg/L) | 1.0–3.0 | – | – | 1.46 | – | – | 0.73 | – | 1.52 | – | – | 2.27 | 2.02 | |
Procalcitonin (PCT) (ng/mL) | < 0.1 | 0.053 | 0.05 | 0.047 | 0.039 | 0.021 | 0.044 | – | 0.068 | – | – | 0.103 | 0.034 | |
C-reactive protein (CRP) (mg/L) | < 10 | 177 | 48.73 | 19.37 | 9.23 | 4.94 | 3.11 | – | 7.43 | – | – | 11.24 | 3.93 | |
Creatine kinase (CK) (U/L) | 55–170 | – | – | 67 | – | – | – | – | – | – | – | – | ||
Creatine kinase-MB (CK-MB) (ng/mL) | 0–2.37 | < 0.22 | – | 0.76 | – | – | – | – | – | – | – | – | 0.84 | |
Myoglobin (MYO) (ng/mL) | 0–110 | 78.3 | – | 103.63 | – | – | – | – | – | – | – | – | 25.36 | |
Cardiac Troponin I (CTnI) (ng/mL) | < 0.04 | < 0.012 | – | < 0.006 | – | – | – | – | – | – | – | – | < 0.006 | |
type B natriuretic peptide (BNP) (pmol/L) | 0–23.1 | 34.1 | – | – | – | – | – | – | – | – | – | |||
Interleukin-6 (IL6) (pg/mL) | 0–7 | 16.19 | – | – | – | – | – | – | – | – | – | < 1.5 | ||
Blood gas assay | PH | 7.35–7.45 | 7.428 | 7.448 | 7.452 | 7.447 | 7.445 | 7.457 | 7.432 | 7.454 | 7.429 | 7.414 | 7.395 | 7.392 |
PCO2 (mmHg) | 35–45 | 43 | 39.1 | 39.1 | 39.2 | 39.7 | 39 | 41.8 | 38.8 | 41.5 | 43.3 | 45.6 | 45.6 | |
PO2 (mmHg) | 75–110 | 64.4 | 137 | 137 | 101 | 113 | 74.2 | 71.3 | 87.1 | 75.7 | 83.8 | 92.5 | 104 | |
Actual sodium bicarbonate (mmol/L) | 21.4–27.3 | 28.4 | 27 | 27.2 | 27 | 27.3 | 27.5 | 27.9 | 27.2 | 27.5 | 27.7 | 27.9 | 27.7 | |
Whole blood alkali surplus (mmol/L) | −3-3 | 3.4 | 2.8 | 3.2 | 2.8 | 3 | 3.5 | 3.6 | 3.3 | 3.1 | 2.6 | 3 | 2.5 | |
Oxygenation index | 400–500 | 157 | 304 | 304 | 259 | 323 | 195 | 188 | 194 | 261 | 399 | 319 | 359 | |
Lactate (mmol/L) | 0.5–1.6 | 1.4 | 1.5 | 1.3 | 1.8 | 1.3 | 1.6 | 1 | 1.2 | 1.3 | 1.5 | 2.4 | 2 | |
Fractional concentration of inspired oxygen (FiO2) (%) | 15.0–100 | 41 | 45 | 45 | 39 | 35 | 38 | 38 | 45 | 29 | 21 | 29 | 29 | |
Blood coagulation function tests | Prothrombin time activity (PTA) (%) | 70–120 | 107 | – | 98 | – | – | – | – | – | 136 | – | – | – |
Prothrombin time (PT) (Sec) | 11–15.1 | 12.7 | – | 13.2 | – | – | – | – | – | 11.5 | – | – | – | |
Prothrombin time International normalizaed ration (PT INR) | 0.75–1.25 | 0.96 | – | 1.01 | – | – | – | – | – | 0.85 | – | – | – | |
Activated partial thromboplastin time (APTT) (Sec) | 28–43.5 | 31.8 | – | 30 | – | – | – | – | – | 28.3 | – | – | – | |
Antithrombin III (AT III) (%) | 85–135 | 100 | – | 105 | – | – | – | – | – | 117 | – | – | – | |
Fibrinogen (FIB) (g/L) | 2–4 | 7.79 | – | 5.37 | – | – | – | – | – | 4.62 | – | – | – | |
D-Dimer (Diffused intravascular coagulation, D-DIC) (μg/mL) | 0–0.5 | 0.95 | – | 0.49 | – | – | – | – | – | 0.29 | – | – | – |